Astex Announces Commencement of Phase I Study for AZD5363 in Anti-Cancer Collaboration with AstraZeneca 12 April 2011/in 2011, News /by webadminAstex Announces Commencement of Phase I Study for AZD5363 in Anti-Cancer Collaboration with AstraZeneca /wp-content/uploads/2016/11/logo.png 0 0 webadmin /wp-content/uploads/2016/11/logo.png webadmin2011-04-12 14:46:232016-11-24 14:47:11Astex Announces Commencement of Phase I Study for AZD5363 in Anti-Cancer Collaboration with AstraZeneca
